Tigo Energy to Unveil Integrated Solar-Plus-Storage Solution for Iberian Market at Genera Energy and Environment Fair
16.2.2023 09:00:00 EET | Business Wire | Press release
Tigo Energy, Inc. (“Tigo” or the “Company”), a leading provider of intelligent solar and energy storage solutions, will showcase and launch the Tigo EI Residential Solar Solution to the Iberian market at the Genera Energy and Environment Fair in Madrid on Wednesday, February 22, 2023. Tigo business and engineering representatives will attend the conference to meet with Spanish PV professionals and to show them the peculiarities of the new Tigo all-in-one system.
The Tigo EI Residential Solar Solution for the European market consists of Tigo TS4 Flex MLPE products, a new line of single-phase and three-phase inverters, modular DC-coupled energy storage components, and the Tigo EI Link, which acts as the communications hub and central connection point for all grid, inverter, PV, and battery connections. Through module-level monitoring, energy data from the EI Residential Storage System is processed by Tigo Energy Intelligence software, allowing installers to monitor and manage their fleet of customer systems with a few mouse clicks. Tigo customers in the EU will also benefit from industry-leading warranties and a skilled, multilingual support team to ensure that installers are never on their own with Tigo products.
“The solar market in Spain is expanding rapidly, in terms of installed PV capacity as well as residential sector installs, so Tigo’s release of the EI Residential Solution here could not be timed more perfectly,” said Pablo Campo Martínez, CEO at DSP Solar. “What makes Tigo so beneficial in the eyes of Spanish installers is the modular and scalable architecture: fast installations and smooth commissioning means more running systems, all managed with a user-friendly monitoring platform characterized by absolute data granularity.”
Genera Energy and Environment Fair attendees can learn about the EI Residential Solution by attending one of a series of presentations during the conference. These sessions include participation by Tigo engineers and will be hosted by Grupo Noria (Tuesday, February 21 at 15:00, Wednesday, February 22 at 11:00, and Thursday, February 23 at 15:00 in booth 8-8B04) and by DSP Solar (Wednesday, February 22 at 16:30 in booth 8-8D15).
“Every aspect of the installation process of the EI Residential Solution is shaped around the installer, combining the simplicity of a plug-and-play system with a streamlined process, from installation to commissioning,” said Ángel Marrero, renewables product manager at Grupo Noria. “With a stackable architecture, the EI solution brilliantly solves the problem related to space constraints faced by our residential customers. For us as installers, the EI Solution provides detailed remote monitoring with powerful software to make operations and maintenance very efficient. Finally, Tigo’s Reclaimed Energy technology is a powerful tool to maximize return on investment and quantify the benefits of optimization in all kinds of PV installations, which benefits installers as well as homeowners.”
In addition to an introduction to the new Tigo EI Residential Solution, Genera attendees can also learn more about the Tigo TS4 Flex MLPE platform. Company representatives will also participate in two panel discussions about the benefits of optimization on commercial and industrial (C&I) solar, which are scheduled to take place on Thursday, February 23 at 11:00 at the Technosun booth (8-8B22) and again at 13:00 at the Albasolar booth (nr 10-10G37). Both discussions will be moderated by Gianluca Pieralli, the Tigo Business Development Manager Iberia and Large Project Coordinator.
To learn more about the Tigo Flex MLPE product family and the Tigo EI Residential Solar Solution, please visit the Genera International Energy and Environment Fair (Ifema, Madrid) from February 21 to 23, 2023. To view a list of partners showcasing Tigo solutions or schedule an appointment with a Tigo representative ahead of time, please visit the Tigo scheduling page here.
About Tigo Energy
Founded in 2007, Tigo is a worldwide leader in the development and manufacture of smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Tigo combines its Flex MLPE (Module Level Power Electronics) and solar optimizer technology with intelligent, cloud-based software capabilities for advanced energy monitoring and control. Tigo MLPE products maximize performance, enable real-time energy monitoring, and provide code-required rapid shutdown at the module level. The company also develops and manufactures products such as inverters and battery storage systems for the residential solar-plus-storage market. For more information, please visit www.tigoenergy.com.
About DSP Solar
Founded in 2007, DSP Solar was born from the commitment with the society and the environment, given the incipient climate change. More than a decade later, many professionals in the sector guide their knowledge and good practices under the protection of the maximum “closeness and trust” to the personalized advice of each client, together with the after-sales technical service has led it to become a benchmark in the sector with a portfolio of more than 10,000 professional clients and 1 million items sold as of 2022.
About Grupo Noria
Grupo Noria is the purchasing center that provides service to a group of brands dedicated to the purchase, sale and distribution of electrical, climate, plumbing, telecommunications and renewable material. Among its associates, up to now, there are three outstanding brands: Novelec, Sinelec and Muntaner Electro. The main objective of Grupo Noria is to collaborate with its clients in improving their business processes, offering them a personalized service of the highest quality. The constant search for new and innovative solutions has led the company to offer a continuous improvement of its services, supporting lighting projects, air conditioning, home automation, automation, fluids, pipes, conductors, energy efficiency and VDI networks. The group was formalized in 2013 and has professionals with extensive experience in this sector. Today it works with an ambitious agenda to accelerate its growth, new commitments and entry into new markets. At the beginning of 2022, he joined UNEF as a result of its strategy of commitment to renewable energies. Grupo Noria has a dedicated team and resources that allow it to manage the service to its customers faster.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005912/en/
Contact information
Gilberto Lembo
EMEA Marketing Manager at Tigo Energy
marketing@tigoenergy.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom